Ionis Pharmaceuticals (IONS) Change in Cash (2009 - 2026)

Ionis Pharmaceuticals' Change in Cash history runs 18 years deep, the most recent figure standing at -$198.9 million for Q1 2026.

• In Q1 2026, Change in Cash fell 999.29% year-over-year to -$198.9 million; the TTM figure through Mar 2026 stood at -$90.8 million (down 7.22% YoY), while the FY2025 annual figure was $130.2 million, up 182.82% from the prior year.
• Change in Cash was -$198.9 million for Q1 2026 at Ionis Pharmaceuticals, down from $33.9 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $115.8 million in Q2 2023 to a low of -$326.7 million in Q1 2022.
• Historically, Change in Cash has averaged -$40.9 million across 5 years, with a median of -$20.6 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Change in Cash sank 2080.95% in 2022, then jumped 662.05% in 2023.
• A 5-year view of Change in Cash shows it stood at -$38.5 million in 2022, then jumped by 222.55% to $47.2 million in 2023, then slumped by 296.01% to -$92.5 million in 2024, then surged by 136.66% to $33.9 million in 2025, then slumped by 686.34% to -$198.9 million in 2026.
• The last three Change in Cash figures came in at -$198.9 million (Q1 2026), $33.9 million (Q4 2025), and $41.0 million (Q3 2025), per Business Quant data.